Use of dasatinib dose-reduction periods to remedy poor surgical wound healing in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kandice E RobertsMichael W DeiningerGerhard C HildebrandtBrian K GackenbachMaxwell M KremPublished in: Leukemia & lymphoma (2020)